CytomX’s Collaboration and Licensing Agreement With Regeneron Pharmaceuticals

Laura Testa
Tagged:

Latham & Watkins LLP represented CytomX in the transaction.Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and CytomX Therapeutics, Inc. (NASDAQ: CTMX) have announced a collaboration and licensing agreement…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

…

This content is for Standard 1 Year members only.
Login Join Now